Volkswagen has been ordered for a third time to provide the court with the names of employees who were involved in approving the emissions cheat software that’s at the center of litigation by Australia’s consumer regulator and several class actions against the German car maker.
The Federal Court has ruled that the Ford Motor Company of Australia engaged in unconscionable conduct towards customers complaining about their troubled PowerShift transmission systems, and ordered the company to pay $10 million in penalties.
Malaysia Airlines has reached agreements to end two cases in Australia brought by families of people who died when a Malaysia Airlines plane was shot down by a missile over Ukraine in 2014.
The applicants in a class action against Johnson & Johnson over allegedly defective vaginal mesh products have won court approval to expand the size of the class and seek an order blocking the sale of devices that don’t include a proper warning.
Kitchen appliance company Thermomix has been hit with a $4.6 million penalty for failing to warn customers of the risk of serious burns associated with its high-end mixer.
There is nothing novel about a dying mesothelioma sufferer seeking damages for the loss of 17 years’ of superannuation and the age pension, the High Court has been told ahead of an expedited hearing on the question of whether the benefits count as compensable loss of earnings in tort cases.
Qantas has settled a lawsuit by a passenger who claims he suffered back and neck injuries after sitting in a faulty seat on a long-haul flight from Sydney to Los Angeles.
Slater and Gordon is mulling a class action on behalf of women who suffered complications after receiving a pelvic mesh implant, in the wake of a damning parliamentary report on the controversial devices.
A long-awaited congressional report has called for an overhaul of medical device regulation in Australia, in the wake of a system-wide failure to protect women who suffered “devastating” consequences after being implanted with faulty vaginal mesh products.
Zoetis is facing a class action from horse owners who say the pharmaceutical company made misleading claims about its Hendra virus drug.